Status:
UNKNOWN
A Single-cell Transcriptome Study in Patients With Non-Hodgkin's Lymphoma
Lead Sponsor:
Ruijin Hospital
Conditions:
Non Hodgkin Lymphoma
Eligibility:
All Genders
14+ years
Brief Summary
Using single-cell RNA sequencing, this study will explore the heterogeneity of lymphoma inside and outside the lymph node, identify tumor specific molecular markers and cell subgroups, explore the dif...
Detailed Description
In recent decades, the incidence of lymphoma has been increasing year by year in the world. Non-Hodgkin lymphoma accounts for about 90% of lymphoma, of which the classification is complex and the effi...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients with pathological confirmed diagnosis of non-Hodgkin's lymphomas.
- Patients with both lymph node and extra nodal involvement, or patients at high risk of relapse, or patients receiving a novel target drug treatment.
Exclusion
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04434833
Start Date
July 1 2020
End Date
June 1 2023
Last Update
July 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Ruijin Hospital
Shanghai, China